CN Patent

CN101466364A — 鼻内施用氯胺酮治疗抑郁症

Assigned to SINAI SCHOOL MEDICINE UNIV NEW YORK · Expires 2009-06-24 · 17y expired

What this patent protects

本发明描述了用于治疗难治性抑郁症的方法和组合物。更具体地，本发明证实了鼻内施用氯胺酮可有效改善患者的抑郁症状，所述患者在本次发作中对一种抗抑郁药的充分试验没有响应、并具有复发或慢性抑郁症状(＞2年)。

USPTO Abstract

本发明描述了用于治疗难治性抑郁症的方法和组合物。更具体地，本发明证实了鼻内施用氯胺酮可有效改善患者的抑郁症状，所述患者在本次发作中对一种抗抑郁药的充分试验没有响应、并具有复发或慢性抑郁症状(＞2年)。

Drugs covered by this patent

esketamine-hydrochloride (ESKETAMINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN101466364A
Jurisdiction: CN
Classification: —
Expires: 2009-06-24
Drug substance claim: No
Drug product claim: No
Assignee: SINAI SCHOOL MEDICINE UNIV NEW YORK
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.